12 Feb 2019
Nikil M
Yashwanth D M
Phaneendra A R
Literature survey
In May 1988: Resolution WHA 41.16 requesting WHO "to initiate programs for the prevention and detection of export, import, and smuggling of falsely labeled, spurious, counterfeited or substandard pharmaceutical preparations, and to cooperate with the Secretary-General of the UN in case provisions of the international drug treaties are violated.
Since then, there have been many amendments such as assigning special task forces globally to fight for the same. Many countries are collectively putting effort to if not eradicate at least reduce the scale in which these trades occur but there has been no impact. The World Health Organization (WHO) estimates that counterfeit medicines worth 73 billion euros are traded annually. Dubious online pharmacies that conceal their true location deliver globally – reaching countries such as Germany, UK, Italy, Spain etc. or the USA. Supplies from illegal Internet pharmacies – those without appropriate certification – are up to 50 percent counterfeits.
According to Outsourcing-Pharma in 2012, 75% of counterfeit drugs supplied worldwide had some origins in India, followed by 7% from Egypt and 6% from China.
The problem areas being:
1. National reputation at stake.
2. Brand protection.
3. Export barriers.
4. Patient protection.
- Effective packing
- Radio-frequency identification (RFID)
- Mass encryption technology
The methods have not been able to be quite effective as they are either expensive or made complex. Thus, we can conclude that there is a necessity for a new kind of system for supply and distribution.